 | • レポートコード：MRC2302B008 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、221ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：材料 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に525.9億ドルであった世界のプロバイオティクス市場規模が、2022年に576.5億ドルになり、2027年には938.2億ドルまで、年平均10.12%で成長すると予測しています。本レポートでは、プロバイオティクスの世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、機能別（骨健康、腸健康、免疫、栄養、生産性）分析、ソース別（バクテリア、酵素）分析、形態別（液体、固体）分析、流通チャネル別（ハイパーマーケット&スーパーマーケット、オンライン、薬局＆ドラッグストア、専門店）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、Alltech, Inc.、Archer Daniels Midland Company、Asahi Group Holdings, Ltd.、Bio Armor Developpement S.A.R.L.、BioCC LLC、Chr. Hansen Holding A/S、DuPont de Nemours, Inc.、Evonik Industries AG、Greentech、Kerry Group PLC、Lallemand Inc.、Land O'lakes, Inc.、Lesaffre & CIE、Lifeway Foods, Inc.、Morinaga Milk Industry Co., Ltd.、Mother Dairy Fruit & Vegetable Pvt. Ltd.、Nestlé S.A.、Novozymes A/S、Probi AB、Probiotical SpA、Provita Eurotech Limited、Reckitt Benckiser Group plc、Roelmi HPC、Royal DSM N.V.、Sabinsa Corporation、Yakult Honsha Co., Ltd.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のプロバイオティクス市場規模：機能別 - 骨健康用プロバイオティクスの市場規模 - 腸健康用プロバイオティクスの市場規模 - 免疫用プロバイオティクスの市場規模 - 栄養用プロバイオティクスの市場規模 - 生産性プロバイオティクスの市場規模 ・世界のプロバイオティクス市場規模：ソース別 - バクテリアの市場規模 - 酵素の市場規模 ・世界のプロバイオティクス市場規模：形態別 - 液体プロバイオティクスの市場規模 - 固体プロバイオティクスの市場規模 ・世界のプロバイオティクス市場規模：流通チャネル別 - ハイパーマーケット&スーパーマーケットチャネルの市場規模 - オンラインチャネルの市場規模 - 薬局＆ドラッグストアチャネルの市場規模 - 専門店チャネルの市場規模 ・世界のプロバイオティクス市場規模：地域別 - 南北アメリカのプロバイオティクス市場規模 アメリカのプロバイオティクス市場規模 カナダのプロバイオティクス市場規模 ブラジルのプロバイオティクス市場規模 ... - アジア太平洋のプロバイオティクス市場規模 日本のプロバイオティクス市場規模 中国のプロバイオティクス市場規模 インドのプロバイオティクス市場規模 韓国のプロバイオティクス市場規模 台湾のプロバイオティクス市場規模 ... - ヨーロッパ/中東/アフリカのプロバイオティクス市場規模 イギリスのプロバイオティクス市場規模 ドイツのプロバイオティクス市場規模 インドのプロバイオティクス市場規模 フランスのプロバイオティクス市場規模 ロシアのプロバイオティクス市場規模 ... - その他地域のプロバイオティクス市場規模 ・競争状況 ・企業情報 |
The Global Probiotics Market size was estimated at USD 52.59 billion in 2021 and expected to reach USD 57.65 billion in 2022, and is projected to grow at a CAGR 10.12% to reach USD 93.82 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Probiotics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the market was studied across Bone Health, Gut Health, Immunity, Nutrition, and Productivity.
Based on Source, the market was studied across Bacteria and Yeast. The Bacteria is further studied across Bifidobacterium, Lactobacilli, and Streptococcus Thermophilus.
Based on Form, the market was studied across Liquide and Solid.
Based on Distribution, the market was studied across Hypermarkets/Supermarkets, Online, Pharmacies/Drugstores, and Specialty Stores.
Based on Application, the market was studied across Dietary Supplements, Feed, and Functional Food & Beverages.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across Arkansas, California, Florida, Illinois, Kentucky, Minnesota, New Jersey, New Mexico, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Probiotics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Probiotics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Probiotics Market, including Alltech, Inc., Archer Daniels Midland Company, Asahi Group Holdings, Ltd., Bio Armor Developpement S.A.R.L., BioCC LLC, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Evonik Industries AG, Greentech, Kerry Group PLC, Lallemand Inc., Land O’lakes, Inc., Lesaffre & CIE, Lifeway Foods, Inc., Morinaga Milk Industry Co., Ltd., Mother Dairy Fruit & Vegetable Pvt. Ltd., Nestlé S.A., Novozymes A/S, Probi AB, Probiotical SpA, Provita Eurotech Limited, Reckitt Benckiser Group plc, Roelmi HPC, Royal DSM N.V., Sabinsa Corporation, and Yakult Honsha Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Probiotics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Probiotics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Probiotics Market?
4. What is the competitive strategic window for opportunities in the Global Probiotics Market?
5. What are the technology trends and regulatory frameworks in the Global Probiotics Market?
6. What is the market share of the leading vendors in the Global Probiotics Market?
7. What modes and strategic moves are considered suitable for entering the Global Probiotics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Inclination Toward Preventive Healthcare
5.1.1.2. Consumption of Probiotic-Based Foods & Beverages
5.1.1.3. Increasing Use of Probiotics in Animal Feeds
5.1.2. Restraints
5.1.2.1. Issues Related to Product Recalls and High Cost of Probiotic Foods
5.1.3. Opportunities
5.1.3.1. Emerging Application in Personalized Nutrition and Precision Medicine
5.1.3.2. Research & Development of Probiotics and Probiotics Food
5.1.4. Challenges
5.1.4.1. Concerns Regarding Addition of Probiotic Cultures to Food and Possible Harmful Effects
5.2. Cumulative Impact of COVID-19
6. Probiotics Market, by Function
6.1. Introduction
6.2. Bone Health
6.3. Gut Health
6.4. Immunity
6.5. Nutrition
6.6. Productivity
7. Probiotics Market, by Source
7.1. Introduction
7.2. Bacteria
7.3.1. Bifidobacterium
7.3.2. Lactobacilli
7.3.3. Streptococcus Thermophilus
7.3. Yeast
8. Probiotics Market, by Form
8.1. Introduction
8.2. Liquide
8.3. Solid
9. Probiotics Market, by Distribution
9.1. Introduction
9.2. Hypermarkets/Supermarkets
9.3. Online
9.4. Pharmacies/Drugstores
9.5. Specialty Stores
10. Probiotics Market, by Application
10.1. Introduction
10.2. Dietary Supplements
10.3. Feed
10.4. Functional Food & Beverages
11. Americas Probiotics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Probiotics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Probiotics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Alltech, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Archer Daniels Midland Company
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Asahi Group Holdings, Ltd.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bio Armor Developpement S.A.R.L.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. BioCC LLC
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Chr. Hansen Holding A/S
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. DuPont de Nemours, Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Evonik Industries AG
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Greentech
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Kerry Group PLC
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Lallemand Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Land O’lakes, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Lesaffre & CIE
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Lifeway Foods, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Morinaga Milk Industry Co., Ltd.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Mother Dairy Fruit & Vegetable Pvt. Ltd.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Nestlé S.A.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Novozymes A/S
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Probi AB
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Probiotical SpA
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Provita Eurotech Limited
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Reckitt Benckiser Group plc
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
15.23. Roelmi HPC
15.23.1. Business Overview
15.23.2. Key Executives
15.23.3. Product & Services
15.24. Royal DSM N.V.
15.24.1. Business Overview
15.24.2. Key Executives
15.24.3. Product & Services
15.25. Sabinsa Corporation
15.25.1. Business Overview
15.25.2. Key Executives
15.25.3. Product & Services
15.26. Yakult Honsha Co., Ltd.
15.26.1. Business Overview
15.26.2. Key Executives
15.26.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing